Jaskiewicz Justyna, Wolf Susan M, Toner Mehmet, Sandlin Rebecca D
MASSACHUSETTS GENERAL HOSPITAL, HARVARD MEDICAL SCHOOL, AND SHRINERS CHILDREN'S BOSTON, BOSTON, MASSACHUSETTS, USA.
UNIVERSITY OF MINNESOTA, MINNEAPOLIS, MINNESOTA, USA.
J Law Med Ethics. 2024;52(3):624-636. doi: 10.1017/jme.2024.125. Epub 2024 Dec 16.
The development of technologies for the biopreservation of infectious organisms requires careful analysis of benefits and risks. This article reviews the regulatory landscape and oversight responsibilities in the United States in respect to pathogen biopreservation. Focused on two globally significant pathogens, and , the article explores advantages and potential risks of biopreservation concerning biosafety, biosecurity and biocontainment.
传染性生物的生物保存技术的发展需要对益处和风险进行仔细分析。本文回顾了美国在病原体生物保存方面的监管情况和监督职责。本文聚焦于两种具有全球重要性的病原体,探讨了生物保存在生物安全、生物安保和生物遏制方面的优势和潜在风险。